ckd and semaglutide Long-term kidney outcomes of in obesity cardiovascular disease in the SELECT trial Evolution of CKD risk after

Weeks 12-48+: Progressive Results Continued steady weight loss toward goal

Read these and more top stories in endocrinology below: Adults prescribed semaglutide may have increased risk for form of optic neuropathy Adults with diabetes or obesity using semaglutide may have an increased risk for nonarteritic anterior ischemic optic neuropathy, a common form of optic neuropathy, according to data published in JAMA Ophthalmology

Many users find it helpful for addressing facial discoloration, and some even notice anti-aging skincare benefits as a lovely bonus

lifestyle interventions: comparing results with semaglutide vs

Chronic vitamin D 3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons

Both are GLP-1based therapies